The information on this page is educational. It describes how Reforge Health thinks about metabolic health. It is not medical advice, diagnosis, or a treatment recommendation. Consult a qualified healthcare provider before making changes to your health regimen.
Fatty liver (NAFLD / MASLD)
Fatty liver. The silent condition that connects the dots.
Non-alcoholic fatty liver disease affects roughly 25 percent of the global population. Most people who have it do not know. The liver does not hurt until it is severely damaged, and standard blood work often misses the early stages entirely.
Fatty liver sits at the centre of the metabolic spectrum. It connects to insulin resistance, visceral adiposity, dyslipidaemia, and systemic inflammation. It is both a consequence of metabolic disruption and a driver of further disruption, a feedback loop that accelerates silently.
We assess liver health through ALT/AST ratios, GGT, ultrasound findings, FibroScan data where available, and the broader metabolic context that standard care ignores when the numbers are "borderline normal."
The spectrum does not wait for a diagnosis.
If you recognise yourself in any of these conditions, or in the spaces between them, the Metabolic Questionnaire is a good starting point. It is not a diagnosis. It is a structured way to map your symptoms and history so that the right conversation can follow.
